StockTipsArenaBeta

BUY Anthem Biosciences Limited — Ashish Chaturmohta, JM Financial

BUYAnthem Biosciences Limited
Anthem Biosciences share price target & all analyst calls

byAshish Chaturmohta, JM FinancialHorizon: 1 year26 Aug 2026via CNBC Awaaz.

Entry₹894.1Inferred
Target₹1,100
Total upside +23.03% (call closed)
Stop loss₹830-7.17% risk
Exit₹83015 Oct 2026, 10:48 am
Stop-loss hit-7.17%
Follow Ashish Chaturmohta for new calls(10% target hit, 21 closed calls)Get alertsWatch ANTHEM for new buy/sell callsGet alertsSee 5 active Long-term calls on ANTHEMSee 542 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 15 Oct 2026
10 supporting8 neutral2 opposing
Supports the BUY call (10)

2 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·21 Aug · 2mo ago

Neutral / worth noting (8)

Nothing found in this tip’s window yet.

Weighs against the BUY call (2)

Anthem Biosciences block deal: Portsmouth Technologies sells 30 lakh shares worth Rs 250 crore

NewsEt-Markets·9 Oct · 5d ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Anthem Biosciences

All analyst calls on Anthem Biosciences

More from Ashish Chaturmohta, JM Financial

Every call and its outcome